1. Home
  2. SNTI vs JZXN Comparison

SNTI vs JZXN Comparison

Compare SNTI & JZXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • JZXN
  • Stock Information
  • Founded
  • SNTI 2016
  • JZXN 2017
  • Country
  • SNTI United States
  • JZXN China
  • Employees
  • SNTI N/A
  • JZXN N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • JZXN Retail-Auto Dealers and Gas Stations
  • Sector
  • SNTI Health Care
  • JZXN Consumer Discretionary
  • Exchange
  • SNTI Nasdaq
  • JZXN Nasdaq
  • Market Cap
  • SNTI 14.1M
  • JZXN 15.3M
  • IPO Year
  • SNTI N/A
  • JZXN 2021
  • Fundamental
  • Price
  • SNTI $2.38
  • JZXN $1.53
  • Analyst Decision
  • SNTI
  • JZXN
  • Analyst Count
  • SNTI 0
  • JZXN 0
  • Target Price
  • SNTI N/A
  • JZXN N/A
  • AVG Volume (30 Days)
  • SNTI 20.3K
  • JZXN 45.1K
  • Earning Date
  • SNTI 11-11-2024
  • JZXN 10-15-2024
  • Dividend Yield
  • SNTI N/A
  • JZXN N/A
  • EPS Growth
  • SNTI N/A
  • JZXN N/A
  • EPS
  • SNTI N/A
  • JZXN N/A
  • Revenue
  • SNTI $338,000.00
  • JZXN $7,597,423.00
  • Revenue This Year
  • SNTI $254.47
  • JZXN N/A
  • Revenue Next Year
  • SNTI $169.66
  • JZXN N/A
  • P/E Ratio
  • SNTI N/A
  • JZXN N/A
  • Revenue Growth
  • SNTI N/A
  • JZXN 81.94
  • 52 Week Low
  • SNTI $1.52
  • JZXN $1.00
  • 52 Week High
  • SNTI $8.48
  • JZXN $67.60
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 40.25
  • JZXN 46.65
  • Support Level
  • SNTI $2.05
  • JZXN $1.42
  • Resistance Level
  • SNTI $2.48
  • JZXN $1.76
  • Average True Range (ATR)
  • SNTI 0.23
  • JZXN 0.17
  • MACD
  • SNTI -0.06
  • JZXN 0.02
  • Stochastic Oscillator
  • SNTI 17.34
  • JZXN 31.30

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About JZXN Jiuzi Holdings Inc.

Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.

Share on Social Networks: